SECONDARY CATARACT INHIBITOR

摘要

1. A pharmaceutical composition for the prevention or treatment of secondary cataract which comprises active ingredient and a pharmaceutically acceptable carrier, characterised in that as the active ingredient N-(3,4-dimethoxycinnamoyl)anthranilic acid represented by the formula is used: or a pharmaceutically acceptable salt thereof. 2. A method for the prevention or treatment of secondary cataract which comprises administering N-(3,4-dimethoxycinnamoyl)anthranilic acid represented by the formula: or a pharmaceutically acceptable salt thereof. 3. A use of N-(3,4-dimethoxycinnamoyl)anthranilic acid represented by the formula: or a pharmaceutically acceptable salt thereof for the manufacture of a pharmaceutical composition for the prevention or treatment of secondary cataract. 4. A use of N-(3,4-dimethoxycinnamoyl)anthranilic acid represented by the formula: or a pharmaceutically acceptable salt thereof as a cataract inhibitor.